High level hematopoietic repopulation by a single early embryonic HSC
| Recipient no. | Tissues transplanted | Time after transplantation | Human CD45+ cells in the recipient blood | Human CD45+ cells in the recipient BM | Human CD45+ cells in the recipient spleen |
| mo | % | % | % | ||
| 1 | AGM region | 4 | 29 | 42 | 4 |
| 2 | AGM region | 4 | 9 | NA | NA |
| 3 | AGM region | 4 | 24 | 45 | 31 |
| 4 | AGM region | 7 | 39 | 86 | 87 |
| 5 | AGM region | 7 | 73 | 93 | 93 |
| 6 | AGM region | 7 | 22 | 71 | 75 |
| 7 | AGM region | 8 | 90 | 94 | 96 |
| 8 | Yolk sac | 4.5 | 7 | NA | NA |
| 9 | Yolk sac | 7.5 | 56 | NA | NA |
| 10 | Yolk sac | 7.5 | 34 | 79 | 87 |
| Recipient no. | Tissues transplanted | Time after transplantation | Human CD45+ cells in the recipient blood | Human CD45+ cells in the recipient BM | Human CD45+ cells in the recipient spleen |
| 1 | AGM region | 4 | 29 | 42 | 4 |
| 2 | AGM region | 4 | 9 | NA | NA |
| 3 | AGM region | 4 | 24 | 45 | 31 |
| 4 | AGM region | 7 | 39 | 86 | 87 |
| 5 | AGM region | 7 | 73 | 93 | 93 |
| 6 | AGM region | 7 | 22 | 71 | 75 |
| 7 | AGM region | 8 | 90 | 94 | 96 |
| 8 | Yolk sac | 4.5 | 7 | NA | NA |
| 9 | Yolk sac | 7.5 | 56 | NA | NA |
| 10 | Yolk sac | 7.5 | 34 | 79 | 87 |
NSG mice transplanted with HSCs derived from the human AGM region or yolk sac were observed for 4–8 mo. At the end of each experiment, the percentage of human CD45+ cells in the recipient peripheral blood, BM, and spleen was assessed by flow cytometry. NA, not assessed as the recipients died.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.